🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 17 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 20/04/2022 | 185,44 | 188,65 | 184,93 | 187,26 | +1,64% | 2,01% | 351.800 |
| 19/04/2022 | 188,30 | 189,92 | 183,43 | 184,24 | -2,42% | 3,45% | 269.700 |
| 18/04/2022 | 191,52 | 193,93 | 188,00 | 188,81 | -1,62% | 3,10% | 278.800 |
| 14/04/2022 | 189,22 | 193,80 | 189,22 | 191,91 | +0,90% | 2,42% | 339.400 |
| 13/04/2022 | 185,69 | 190,89 | 185,69 | 190,19 | +1,89% | 2,80% | 196.800 |
| 12/04/2022 | 185,14 | 189,39 | 185,06 | 186,66 | +0,60% | 2,34% | 204.000 |
| 11/04/2022 | 188,48 | 188,90 | 185,09 | 185,54 | -1,97% | 2,02% | 203.100 |
| 08/04/2022 | 191,08 | 191,83 | 188,91 | 189,27 | -0,44% | 1,53% | 820.100 |
| 07/04/2022 | 185,06 | 191,69 | 184,01 | 190,11 | +2,50% | 4,15% | 624.000 |
| 06/04/2022 | 183,75 | 188,82 | 183,75 | 185,48 | +0,42% | 2,76% | 471.100 |
| 05/04/2022 | 182,67 | 186,86 | 182,21 | 184,71 | +0,37% | 2,55% | 354.600 |
| 04/04/2022 | 184,85 | 188,79 | 183,58 | 184,03 | -0,34% | 2,82% | 613.000 |
| 01/04/2022 | 180,60 | 184,90 | 180,13 | 184,65 | +2,92% | 2,64% | 424.400 |
| 31/03/2022 | 175,63 | 180,13 | 173,80 | 179,41 | +2,15% | 3,60% | 395.600 |
| 30/03/2022 | 178,65 | 179,81 | 173,54 | 175,63 | -1,59% | 3,51% | 457.100 |
| 29/03/2022 | 175,64 | 178,56 | 173,67 | 178,46 | +1,84% | 2,78% | 422.600 |
| 28/03/2022 | 175,50 | 178,20 | 174,51 | 175,23 | +0,22% | 2,10% | 555.600 |
| 25/03/2022 | 178,68 | 179,15 | 174,05 | 174,84 | -2,25% | 2,85% | 895.100 |
| 24/03/2022 | 178,24 | 181,48 | 177,40 | 178,87 | +0,61% | 2,29% | 215.100 |
| 23/03/2022 | 179,11 | 181,23 | 176,97 | 177,78 | -0,86% | 2,38% | 251.500 |
| 22/03/2022 | 181,45 | 181,91 | 178,41 | 179,33 | -1,56% | 1,93% | 270.200 |
| 21/03/2022 | 182,98 | 183,93 | 179,70 | 182,17 | +0,54% | 2,31% | 300.700 |
| 18/03/2022 | 182,23 | 185,13 | 178,86 | 181,20 | -1,78% | 3,44% | 543.400 |
| 17/03/2022 | 182,55 | 185,38 | 179,32 | 184,49 | +1,06% | 3,32% | 327.900 |
| 16/03/2022 | 179,31 | 182,65 | 176,05 | 182,55 | +2,09% | 3,68% | 284.400 |
| 15/03/2022 | 174,90 | 179,80 | 174,90 | 178,82 | +2,18% | 2,80% | 395.100 |
| 14/03/2022 | 174,29 | 179,45 | 172,94 | 175,00 | +1,16% | 3,74% | 501.000 |
| 11/03/2022 | 166,32 | 177,53 | 158,38 | 173,00 | +3,11% | 11,51% | 1.511.100 |
| 10/03/2022 | 168,17 | 168,64 | 164,27 | 167,78 | -1,26% | 2,60% | 436.900 |
| 09/03/2022 | 174,42 | 174,83 | 167,27 | 169,92 | -1,48% | 4,33% | 697.400 |